AstraZeneca has announced the cancellation of its £450 million investment in a new vaccine plant in Liverpool, attributing the decision to significant cuts in government funding and support. This move is a major setback for local political leaders, including Labour figures like Rachel Reeves, who have been advocating for growth and investment in the region. The decision has sparked criticism, with some accusing the government of failing to uphold commitments to support important pharmaceutical investments. Local officials are seeking to reopen discussions with AstraZeneca to explore potential alternatives.